NEMCL
NEWMONT Corp /DE/
$112.00
0.00%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
May 13, 2026
SEC
Former officer Jennifer Cmil filed a Form 144 notice of intent to sell 15,082 common shares (approx. $1.8M at filing) vi
144 — Impact 2/10
May 1, 2026
SEC
Officer Peter Toth filed a Form 144 indicating intent to sell 3,000 common shares of Newmont Corp, valued at approximate
144 — Impact 2/10
Apr 23, 2026
SEC
Newmont reported strong Q1 2026 results with a 24.7% EPS beat, driven by a record $4,900/oz gold price and lower costs,
8-K — Impact 8/10
Analyst Ratings
9Strong Buy
16Buy
5Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
144
2/10
Former officer Jennifer Cmil filed a Form 144 notice of intent to sell 15,082 common shares (approx. $1.8M at filing) vi
May 13, 2026
NEUTRAL
144
2/10
Officer Peter Toth filed a Form 144 indicating intent to sell 3,000 common shares of Newmont Corp, valued at approximate
May 1, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.8/10.
NEUTRAL
144
2/10
Former officer Jennifer Cmil filed a Form 144 notice of intent to sell 15,082 common shares (approx.
May 13, 2026
NEUTRAL
144
2/10
Officer Peter Toth filed a Form 144 indicating intent to sell 3,000 common shares of Newmont Corp, v
May 1, 2026
BULLISH
8-K
8/10
Newmont reported strong Q1 2026 results with a 24.7% EPS beat, driven by a record $4,900/oz gold pri
Apr 23, 2026
NEUTRAL
DEFA14A
3/10
Newmont Corporation filed a definitive proxy statement (DEFA14A) for its 2026 Annual Stockholder Mee
Mar 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 83% buy across 30 analysts — 9 strong buy, 16 buy, 5 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $6.5B | 22.1% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $7.2B | 30.1% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $28.8B | 27.2% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $30.6B | 6.1% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 9 | 16 | 5 | 0 | 0 | 83% | |
| May 1, 2026 | 9 | 16 | 5 | 0 | 0 | 83% | |
| Apr 1, 2026 | 9 | 16 | 4 | 0 | 0 | 86% | |
| Mar 1, 2026 | 8 | 16 | 5 | 0 | 0 | 83% | |
| Feb 1, 2026 | 8 | 16 | 5 | 0 | 0 | 83% | |
| Jan 1, 2026 | 7 | 16 | 4 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.